Status:
COMPLETED
A Prospective Researcher-led Clinical Study of Neopep-S-based EasyDew MD Regen Cream
Lead Sponsor:
Eun-ji Kim
Conditions:
Skin Lesion
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This clinical study is conducted prospectively for 3 months after medical device treatment. It is a comparative clinical study of the leading control group.
Detailed Description
Subjects need tissue transplantation to repair skin defects, so partial layer skin transplantation is performed. After proceeding, the patient is no longer subject to exudation. Subjects (and/or legal...
Eligibility Criteria
Inclusion
- adults over the age of 19
- Subjects with partial layer skin transplantation
- There is no evidence of infection in the skin transplant process, and exudate is no longer present a person who does not arise
- Decide to participate in this clinical study arbitrarily and in the written informed consent a person
Exclusion
- showing signs of infection requiring antibiotic administration throughout the body or skin transplantation Case
- In situations where the requirements of a clinical study cannot be complied with
- When the researcher's judgment determines that the participation of the study is inappropriate (e.g. Kelloid personality)
Key Trial Info
Start Date :
November 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05994781
Start Date
November 11 2022
End Date
June 30 2023
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Gyeonggi-do, South Korea